Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice

J Immunol. 2005 Jun 15;174(12):7904-11. doi: 10.4049/jimmunol.174.12.7904.

Abstract

Mice lacking functional CD1d genes were used to study mechanisms of resistance to the protozoan parasite Toxoplasma gondii. Wild-type (WT) BALB/c mice, CD1d-deficient BALB/c mice, and WT C57BL/6 mice all survived an acute oral infection with a low dose of mildly virulent strain ME49 T. gondii cysts. In contrast, most CD1d-deficient C57BL/6 mice died within 2 wk of infection. Despite having parasite burdens that were only slightly higher than WT mice, CD1d-deficient C57BL/6 mice displayed greater weight loss and intestinal pathology. In C57BL/6 mice, CD4(+) cells can cause intestinal pathology during T. gondii infection. Compared with WT mice, infected CD1d-deficient C57BL/6 mice had higher frequencies and numbers of activated (CD44(high)) CD4(+) cells in mesenteric lymph nodes. Depletion of CD4(+) cells from CD1d-deficient mice reduced weight loss and prolonged survival, demonstrating a functional role for CD4(+) cells in their increased susceptibility to T. gondii infection. CD1d-deficient mice are deficient in Valpha14(+) T cells, a major population of NKT cells. Involvement of these cells in resistance to T. gondii was investigated using gene-targeted Jalpha18-deficient C57BL/6 mice, which are deficient in Valpha14(+) T cells. These mice did not succumb to acute infection, but experienced greater weight loss and more deaths than B6 mice during chronic infection, indicating that Valpha14(+) cells contribute to resistance to T. gondii. The data identify CD4(+) cells as a significant component of the marked susceptibility to T. gondii infection observed in CD1d-deficient C57BL/6 mice, and establish T. gondii as a valuable tool for deciphering CD1d-dependent protective mechanisms.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Disease
  • Administration, Oral
  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use
  • Antigens, CD1 / biosynthesis
  • Antigens, CD1 / genetics*
  • Antigens, CD1 / physiology
  • Antigens, CD1d
  • Antigens, Protozoan / administration & dosage
  • Antigens, Protozoan / immunology
  • CD4 Antigens / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • CD4-Positive T-Lymphocytes / parasitology
  • Genetic Predisposition to Disease / genetics*
  • Immunity, Innate / genetics
  • Intestinal Diseases, Parasitic / genetics
  • Intestinal Diseases, Parasitic / immunology
  • Intestinal Diseases, Parasitic / pathology
  • Intestinal Mucosa / immunology
  • Intestinal Mucosa / pathology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptors, Antigen, T-Cell, alpha-beta / deficiency
  • Receptors, Antigen, T-Cell, alpha-beta / genetics
  • Toxoplasma / growth & development
  • Toxoplasma / immunology
  • Toxoplasma / pathogenicity
  • Toxoplasmosis, Animal / genetics
  • Toxoplasmosis, Animal / immunology*
  • Toxoplasmosis, Animal / pathology*
  • Toxoplasmosis, Animal / therapy

Substances

  • Antibodies, Monoclonal
  • Antigens, CD1
  • Antigens, CD1d
  • Antigens, Protozoan
  • CD4 Antigens
  • Receptors, Antigen, T-Cell, alpha-beta